Trials / Completed
CompletedNCT00097240
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)
The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
Conditions
Timeline
- Start date
- 2005-01-01
- Completion
- 2009-09-01
- First posted
- 2004-11-22
- Last updated
- 2010-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00097240. Inclusion in this directory is not an endorsement.